Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2908087463;87464;87465 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
N2AB2743982540;82541;82542 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
N2A2651279759;79760;79761 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
N2B2001560268;60269;60270 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
Novex-12014060643;60644;60645 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
Novex-22020760844;60845;60846 chr2:178558116;178558115;178558114chr2:179422843;179422842;179422841
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Ig-145
  • Domain position: 36
  • Structural Position: 50
  • Q(SASA): 0.2288
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/G rs760115899 -2.444 0.324 N 0.528 0.34 0.326074293725 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.91E-06 0
R/G rs760115899 -2.444 0.324 N 0.528 0.34 0.326074293725 gnomAD-4.0.0 1.59111E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85788E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.4867 ambiguous 0.4996 ambiguous -0.877 Destabilizing 0.116 N 0.517 neutral None None None None N
R/C 0.2145 likely_benign 0.2086 benign -0.833 Destabilizing 0.981 D 0.646 neutral None None None None N
R/D 0.8484 likely_pathogenic 0.8611 pathogenic 0.104 Stabilizing 0.388 N 0.59 neutral None None None None N
R/E 0.459 ambiguous 0.48 ambiguous 0.236 Stabilizing 0.116 N 0.534 neutral None None None None N
R/F 0.6032 likely_pathogenic 0.5991 pathogenic -0.796 Destabilizing 0.932 D 0.635 neutral None None None None N
R/G 0.4077 ambiguous 0.4625 ambiguous -1.171 Destabilizing 0.324 N 0.528 neutral N 0.503695777 None None N
R/H 0.152 likely_benign 0.1541 benign -1.543 Destabilizing 0.818 D 0.519 neutral None None None None N
R/I 0.2994 likely_benign 0.3005 benign -0.091 Destabilizing 0.773 D 0.624 neutral N 0.484416582 None None N
R/K 0.0725 likely_benign 0.0751 benign -0.631 Destabilizing None N 0.155 neutral N 0.332951189 None None N
R/L 0.2921 likely_benign 0.2851 benign -0.091 Destabilizing 0.388 N 0.528 neutral None None None None N
R/M 0.2881 likely_benign 0.2948 benign -0.459 Destabilizing 0.932 D 0.59 neutral None None None None N
R/N 0.713 likely_pathogenic 0.7282 pathogenic -0.241 Destabilizing 0.388 N 0.517 neutral None None None None N
R/P 0.9104 likely_pathogenic 0.9244 pathogenic -0.333 Destabilizing 0.818 D 0.611 neutral None None None None N
R/Q 0.1232 likely_benign 0.1263 benign -0.369 Destabilizing 0.241 N 0.543 neutral None None None None N
R/S 0.6174 likely_pathogenic 0.6547 pathogenic -1.057 Destabilizing 0.193 N 0.507 neutral N 0.503522418 None None N
R/T 0.3699 ambiguous 0.3923 ambiguous -0.733 Destabilizing 0.324 N 0.523 neutral N 0.503522418 None None N
R/V 0.3778 ambiguous 0.3748 ambiguous -0.333 Destabilizing 0.69 D 0.606 neutral None None None None N
R/W 0.2473 likely_benign 0.2493 benign -0.496 Destabilizing 0.981 D 0.665 neutral None None None None N
R/Y 0.4927 ambiguous 0.4798 ambiguous -0.195 Destabilizing 0.932 D 0.611 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.